Mas C - Search Results

1

The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.

Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A. Melotti A, et al. Among authors: mas c. EMBO Mol Med. 2014 Oct;6(10):1263-78. doi: 10.15252/emmm.201404084. EMBO Mol Med. 2014. PMID: 25143352 Free PMC article.

2

Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion.

Varnat F, Duquet A, Malerba M, Zbinden M, Mas C, Gervaz P, Ruiz i Altaba A. Varnat F, et al. Among authors: mas c. EMBO Mol Med. 2009 Sep;1(6-7):338-51. doi: 10.1002/emmm.200900039. EMBO Mol Med. 2009. PMID: 20049737 Free PMC article.

3

Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells.

Seth C, Mas C, Conod A, Mueller J, Siems K, Kuciak M, Borges I, Ruiz i Altaba A. Seth C, et al. Among authors: mas c. PLoS One. 2016 Dec 14;11(12):e0168170. doi: 10.1371/journal.pone.0168170. eCollection 2016. PLoS One. 2016. PMID: 27973612 Free PMC article.

4

Interference with HH-GLI signaling inhibits prostate cancer.

Stecca B, Mas C, Ruiz i Altaba A. Stecca B, et al. Among authors: mas c. Trends Mol Med. 2005 May;11(5):199-203. doi: 10.1016/j.molmed.2005.03.004. Trends Mol Med. 2005. PMID: 15882606 Review.

5

Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations.

Mas C, Ruiz i Altaba A. Mas C, et al. Biochem Pharmacol. 2010 Sep 1;80(5):712-23. doi: 10.1016/j.bcp.2010.04.016. Epub 2010 Apr 20. Biochem Pharmacol. 2010. PMID: 20412786 Review.

6

Chimeric NANOG repressors inhibit glioblastoma growth in vivo in a context-dependent manner.

Kuciak M, Mas C, Borges I, Sánchez-Gómez P, Ruiz I Altaba A. Kuciak M, et al. Among authors: mas c. Sci Rep. 2019 Mar 7;9(1):3891. doi: 10.1038/s41598-019-39473-y. Sci Rep. 2019. PMID: 30846719 Free PMC article.

7

The Gli code: an information nexus regulating cell fate, stemness and cancer.

Ruiz i Altaba A, Mas C, Stecca B. Ruiz i Altaba A, et al. Among authors: mas c. Trends Cell Biol. 2007 Sep;17(9):438-47. doi: 10.1016/j.tcb.2007.06.007. Epub 2007 Sep 12. Trends Cell Biol. 2007. PMID: 17845852 Free PMC article. Review.

8

Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways.

Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, Beermann F, Ruiz i Altaba A. Stecca B, et al. Among authors: mas c. Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5895-900. doi: 10.1073/pnas.0700776104. Epub 2007 Mar 28. Proc Natl Acad Sci U S A. 2007. PMID: 17392427 Free PMC article.

9

Antitumour efficacy of the selumetinib and trametinib MEK inhibitors in a combined human airway-tumour-stroma lung cancer model.

Mas C, Boda B, CaulFuty M, Huang S, Wiszniewski L, Constant S. Mas C, et al. J Biotechnol. 2015 Jul 10;205:111-9. doi: 10.1016/j.jbiotec.2015.01.012. Epub 2015 Jan 20. J Biotechnol. 2015. PMID: 25615947

10

Connexin 36 controls synchronization of Ca2+ oscillations and insulin secretion in MIN6 cells.

Calabrese A, Zhang M, Serre-Beinier V, Caton D, Mas C, Satin LS, Meda P. Calabrese A, et al. Among authors: mas c. Diabetes. 2003 Feb;52(2):417-24. doi: 10.2337/diabetes.52.2.417. Diabetes. 2003. PMID: 12540616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

137 results

Search Page

Filters